Genomic Health Inc. (GHDX) Declined -5.77% or -4.3 To Price $70.33 On Friday


Genomic Health Inc. (GHDX) declined -5.77% or -4.3 to $70.33. It is close to 250220 shares traded, which is 53.33% compare to the average total volume 469182. The market cap of GHDX is $2.60 billion. The year to date change is 14.18%. The 52 week price range is from $30.04 to $92.18. Price of GHDX have changed 0.17% during last week. It have changed -10.45% over last month, 13.13% over last 3 months, 14.89% over last 6 months and 130.70% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for GHDX is 75.51. It is 7.37% above current price. The 200-day Moving Averages for GHDX is 65.54. It is -6.81% below current price. The 52-week High is 92.18. It is 31.07% from the current price. The 52-week Low is 30.04. It is -57.29% from current price.

There are some statistics of GHDX. It is has market cap $2.60 billion. The share outstanding is 36.90 million. The average volume is 469182. The percent of top 15 Institution holding is 114.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of GHDX is 11.20%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of GHDX is 9.07%.


Tags:

Share this post